Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
01:17pm, Wednesday, 10'th Jan 2024
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
U.S. IPO Weekly Recap: 2024 IPO Market Starts Off With $2B Additions To The Pipeline
11:20am, Saturday, 06'th Jan 2024
While the calendar was quiet this past week, six IPOs joined the pipeline, two of which we estimate could raise $1 billion or more. Three biotechs filed to raise $100 million.
Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
08:00am, Friday, 05'th Jan 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce financial results for the fourth quarter and full year ending December 31, 2023, on February 8, 2024.
Still Worried About a 2024 Recession? 7 Stocks to Watch.
06:28pm, Thursday, 04'th Jan 2024
One of the main themes of 2023 may be relief – that is, relief that we avoided a downcycle – and so it begs the question: why talk about 2024 recession worries? More to the point, why deal with re
January's 54 Dividend Kings: Buy 8, Watch 5
11:14am, Sunday, 31'st Dec 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the
3 Top Dividend Stocks I Can't Wait to Buy in 2024
07:40am, Friday, 29'th Dec 2023
Clearway Energy has the power to deliver high-end dividend growth in 2024. Kenvue should deliver the first of many dividend increases in the coming year.
Forever Favorites: 7 Dividend Stocks to Buy and Never Sell
05:00pm, Tuesday, 19'th Dec 2023
Some investments just look after themselves. They are “set it and forget it” kind of stocks.
Kenvue Shares Are Rising. Tylenol Litigation Fades Into the Rearview.
01:21pm, Tuesday, 19'th Dec 2023
A ruling hurts litigation against Kenvue that alleges a link between prenatal exposure to the company's Tylenol and autism spectrum disorder or ADHD.
Kenvue shares rise after favorable court ruling in Tylenol litigation
08:22am, Tuesday, 19'th Dec 2023
Shares of Tylenol maker Kenvue Inc. KVUE, +0.10% gained more than 5% premarket on Tuesday after a federal court judge in New York ruled that plaintiffs' expert testimony will be blocked in a case invo
Naval Task Force; Japanese Takeover
08:00am, Tuesday, 19'th Dec 2023
Naval Task Force; Japanese Takeover
Kenvue: A High-Quality Consumer Health Company on Sale
02:51pm, Tuesday, 12'th Dec 2023
In May, Kenvue Inc. (KVUE, Financial) successfully concluded its separation from Johnson & Johnson (JNJ, Financial); however, its stock has experienced a decline about 25% since the completion of this
Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul
03:42pm, Monday, 11'th Dec 2023
The last four years on Wall Street gave investors whiplash. A decade-long bull market came to a screeching halt as the global pandemic brought on one of the worst market crashes in recent memory.
3 Dividend Stocks Worthy Of A Buy In December 2023
09:37am, Monday, 04'th Dec 2023
November was the best month for the S&P 500 since July 2022, breaking a three-month losing streak. The stock market appears overvalued after the strong November performance, suggesting a minor pullbac
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
09:06am, Thursday, 30'th Nov 2023
The initial public offering (IPO) market has not done well in 2023. The most recent deals have faltered, falling below their IPO pricing on day one or soon after.
2023's most anticipated IPOs weren't always the big winners
06:05am, Wednesday, 29'th Nov 2023
So far in 2023, 146 companies have gone public in the U.S. markets, down 16.09% from the same time last year. Although the IPO market has been choppy amid higher interest rates and broad equity market
